Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma
暂无分享,去创建一个
L. Rybicki | M. Kalaycio | R. Chakraborty | J. Valent | Diana Basali | M. Karam | J. Reed | Nathaniel Rosko | Hayley Dysert | Kristen Schlueter